Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ICGC-ARGO precision medicine: familial matters in pancreatic cancer.

The Lancet. Oncology - 1 Jan 2022

Milella Michele, Luchini Claudio, Lawlor Rita T, Johns Amber L, Casolino Raffaella, Yoshino Takayuki, Biankin Andrew V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Pancreatic Ductal
Share to High-Throughput Nucleotide Sequencing
Share to Homologous Recombination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pancreatic Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 34973218
DOI: 10.1016/S1470-2045(21)00703-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ICGC-ARGO precision medicine: familial matters in pancreatic cancer.PMID 34973218Read ↗

Familial pancreatic cancer: Concept, management and issues.Semantic proximity Read ↗

Familial pancreatic cancer.Semantic proximity Read ↗

Pancreatic cancer--more familial than you thought.Semantic proximity Read ↗

Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.Semantic proximity Read ↗

Genetics, Genomics and Emerging Molecular Therapies of Pancreatic CancerSemantic proximity Read ↗

Familial pancreatic cancer: a review and latest advances.Semantic proximity Read ↗

An introduction to pancreatic adenocarcinoma genetics, pathology and therapy.Semantic proximity Read ↗

Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsSemantic proximity Read ↗

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.Semantic proximity Read ↗

The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.Semantic proximity Read ↗

Genetics of pancreatic cancer: where are we now? Where are we going?Semantic proximity Read ↗

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.